US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist
  • 1.840
  • 0.0000.00%
Close Mar 27 16:00 ET
  • 1.890
  • +0.050+2.72%
Pre 08:06 ET
83.03MMarket Cap-1533P/E (TTM)

Cue Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
2,988.24%2.1M
5,215.38%1.38M
-81.30%187K
-91.67%1.25M
-98.17%151.23K
-97.16%68K
-99.05%26K
-35.61%1M
373.68%14.94M
1,636.57%8.25M
Operating revenue
2,988.24%2.1M
5,215.38%1.38M
-81.30%187K
-91.67%1.25M
-98.17%151.23K
-97.16%68K
-99.05%26K
-35.61%1M
373.68%14.94M
1,636.57%8.25M
Cost of revenue
Gross profit
Operating expense
21.80%13.52M
11.40%14.9M
-10.97%13.57M
-6.66%54.75M
-6.89%15.04M
-27.99%11.1M
2.55%13.37M
8.29%15.24M
21.70%58.65M
41.03%16.15M
Selling and administrative expenses
3.32%3.65M
12.35%4.25M
-19.01%4.18M
-6.58%16.17M
-20.30%3.7M
-14.47%3.53M
-11.64%3.78M
21.18%5.16M
18.12%17.31M
31.96%4.65M
-General and administrative expense
3.32%3.65M
12.35%4.25M
-19.01%4.18M
-6.58%16.17M
-20.30%3.7M
-14.47%3.53M
-11.64%3.78M
21.18%5.16M
18.12%17.31M
31.96%4.65M
Research and development costs
30.42%9.87M
11.03%10.65M
-6.85%9.39M
-6.70%38.58M
-1.47%11.33M
-32.93%7.57M
9.47%9.59M
2.71%10.08M
23.26%41.35M
43.69%11.5M
Operating profit
-3.52%-11.42M
-1.27%-13.52M
6.03%-13.38M
-22.40%-53.5M
-88.58%-14.88M
15.26%-11.03M
-29.55%-13.35M
-13.74%-14.24M
2.95%-43.71M
28.08%-7.89M
Net non-operating interest income expense
444.74%414K
381.36%332K
1,694.12%271K
367.18%214.43K
6,914.55%273.43K
204.00%76K
-591.67%-118K
-230.77%-17K
-90.11%45.9K
-95.00%3.9K
Non-operating interest income
250.00%700K
540.91%564K
7,912.50%641K
1,922.40%928.24K
16,119.65%632.24K
700.00%200K
266.67%88K
-38.46%8K
-90.11%45.9K
-95.00%3.9K
Non-operating interest expense
130.65%286K
12.62%232K
1,380.00%370K
--713.82K
--358.82K
--124K
--206K
--25K
--0
--0
Other net income (expense)
276.63K
18.63K
258K
Special income (charges)
--0
--0
----
--276.63K
--18.63K
--0
--258K
----
--0
--0
-Less:Impairment of capital assets
--0
--0
----
---276.63K
---18.63K
--0
---258K
----
--0
--0
Income before tax
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-21.40%-53.01M
-84.97%-14.59M
15.69%-10.96M
-28.49%-13.21M
-13.99%-14.26M
2.05%-43.67M
27.60%-7.89M
Income tax
0
140.00%495K
Net income
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.05%-14.59M
15.69%-10.96M
-28.49%-13.21M
-13.99%-14.26M
1.39%-44.16M
24.49%-8.38M
Net income continuous Operations
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.05%-14.59M
15.69%-10.96M
-28.49%-13.21M
-13.99%-14.26M
1.39%-44.16M
24.49%-8.38M
Minority interest income
Net income attributable to the parent company
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.05%-14.59M
15.69%-10.96M
-28.49%-13.21M
-13.99%-14.26M
1.39%-44.16M
24.49%-8.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.05%-14.59M
15.69%-10.96M
-28.49%-13.21M
-13.99%-14.26M
1.39%-44.16M
24.49%-8.38M
Basic earnings per share
22.58%-0.24
21.62%-0.29
34.09%-0.29
-5.67%-1.49
-52.00%-0.38
24.39%-0.31
-12.12%-0.37
-7.32%-0.44
9.62%-1.41
30.56%-0.25
Diluted earnings per share
22.58%-0.24
21.62%-0.29
34.09%-0.29
-5.67%-1.49
-52.00%-0.38
24.39%-0.31
-12.12%-0.37
-7.32%-0.44
9.62%-1.41
30.56%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 2,988.24%2.1M5,215.38%1.38M-81.30%187K-91.67%1.25M-98.17%151.23K-97.16%68K-99.05%26K-35.61%1M373.68%14.94M1,636.57%8.25M
Operating revenue 2,988.24%2.1M5,215.38%1.38M-81.30%187K-91.67%1.25M-98.17%151.23K-97.16%68K-99.05%26K-35.61%1M373.68%14.94M1,636.57%8.25M
Cost of revenue
Gross profit
Operating expense 21.80%13.52M11.40%14.9M-10.97%13.57M-6.66%54.75M-6.89%15.04M-27.99%11.1M2.55%13.37M8.29%15.24M21.70%58.65M41.03%16.15M
Selling and administrative expenses 3.32%3.65M12.35%4.25M-19.01%4.18M-6.58%16.17M-20.30%3.7M-14.47%3.53M-11.64%3.78M21.18%5.16M18.12%17.31M31.96%4.65M
-General and administrative expense 3.32%3.65M12.35%4.25M-19.01%4.18M-6.58%16.17M-20.30%3.7M-14.47%3.53M-11.64%3.78M21.18%5.16M18.12%17.31M31.96%4.65M
Research and development costs 30.42%9.87M11.03%10.65M-6.85%9.39M-6.70%38.58M-1.47%11.33M-32.93%7.57M9.47%9.59M2.71%10.08M23.26%41.35M43.69%11.5M
Operating profit -3.52%-11.42M-1.27%-13.52M6.03%-13.38M-22.40%-53.5M-88.58%-14.88M15.26%-11.03M-29.55%-13.35M-13.74%-14.24M2.95%-43.71M28.08%-7.89M
Net non-operating interest income expense 444.74%414K381.36%332K1,694.12%271K367.18%214.43K6,914.55%273.43K204.00%76K-591.67%-118K-230.77%-17K-90.11%45.9K-95.00%3.9K
Non-operating interest income 250.00%700K540.91%564K7,912.50%641K1,922.40%928.24K16,119.65%632.24K700.00%200K266.67%88K-38.46%8K-90.11%45.9K-95.00%3.9K
Non-operating interest expense 130.65%286K12.62%232K1,380.00%370K--713.82K--358.82K--124K--206K--25K--0--0
Other net income (expense) 276.63K18.63K258K
Special income (charges) --0--0------276.63K--18.63K--0--258K------0--0
-Less:Impairment of capital assets --0--0-------276.63K---18.63K--0---258K------0--0
Income before tax -0.46%-11.01M0.17%-13.19M8.04%-13.11M-21.40%-53.01M-84.97%-14.59M15.69%-10.96M-28.49%-13.21M-13.99%-14.26M2.05%-43.67M27.60%-7.89M
Income tax 0140.00%495K
Net income -0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.05%-14.59M15.69%-10.96M-28.49%-13.21M-13.99%-14.26M1.39%-44.16M24.49%-8.38M
Net income continuous Operations -0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.05%-14.59M15.69%-10.96M-28.49%-13.21M-13.99%-14.26M1.39%-44.16M24.49%-8.38M
Minority interest income
Net income attributable to the parent company -0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.05%-14.59M15.69%-10.96M-28.49%-13.21M-13.99%-14.26M1.39%-44.16M24.49%-8.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.05%-14.59M15.69%-10.96M-28.49%-13.21M-13.99%-14.26M1.39%-44.16M24.49%-8.38M
Basic earnings per share 22.58%-0.2421.62%-0.2934.09%-0.29-5.67%-1.49-52.00%-0.3824.39%-0.31-12.12%-0.37-7.32%-0.449.62%-1.4130.56%-0.25
Diluted earnings per share 22.58%-0.2421.62%-0.2934.09%-0.29-5.67%-1.49-52.00%-0.3824.39%-0.31-12.12%-0.37-7.32%-0.449.62%-1.4130.56%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg